 |
|
Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
Ji Hyun Kim, Eujin Park, Hye Sun Hyun, Myung Hyun Cho, Yo Han Ahn, Hyun Jin Choi, Hee Gyung Kang, Il-Soo Ha, Hae Il Cheong
Kidney Res Clin Pract. 2017;36(3):257-263. Published online 2017 Sep 30 DOI: https://doi.org/10.23876/j.krcp.2017.36.3.257
|
|
Citations to this article as recorded by
 Rituximab Use for the Treatment of Childhood Nephrotic Syndrome by Canadian Pediatric Nephrologists: A National Survey
Cory Meeuwisse, Catherine J. Morgan, Susan Samuel, R Todd Alexander, Sara Rodriguez-Lopez
Canadian Journal of Kidney Health and Disease.2022; 9: 205435812210799. CrossRef Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study
Eugene Yu-hin Chan, Ellen L.M. Yu, Andrea Angeletti, Zainab Arslan, Biswanath Basu, Olivia Boyer, Chang-Yien Chan, Manuela Colucci, Guillaume Dorval, Claire Dossier, Stefania Drovandi, Gian Marco Ghiggeri, Debbie S. Gipson, Riku Hamada, Julien Hogan, Kenj
Journal of the American Society of Nephrology.2022; 33(6): 1193. CrossRef Tedavisi zor nefrotik sendromlu çocuklarda rituksimab tedavisi
Gönül PARMAKSIZ
Cukurova Medical Journal.2022; 47(2): 489. CrossRef Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome
Eugene Yu-hin Chan, Desmond Yat-hin Yap, Manuela Colucci, Alison Lap-tak Ma, Rulan S. Parekh, Kjell Tullus
Clinical Journal of the American Society of Nephrology.2022;[Epub] CrossRef Rituximab in children with steroid sensitive nephrotic syndrome: in quest of the optimal regimen
Eugene Yu-hin Chan, Kjell Tullus
Pediatric Nephrology.2021; 36(6): 1397. CrossRef Low regulatory T-cells: A distinct immunological subgroup in minimal change nephrotic syndrome with early relapse following rituximab therapy
Chang-Yien Chan, Sharon Teo, Liangjian Lu, Yiong-Huak Chan, Perry Yew-Weng Lau, Mya Than, Stanley C Jordan, Kong-Peng Lam, Kar-Hui Ng, Hui-Kim Yap
Translational Research.2021; 235: 48. CrossRef A Retrospective Analysis of Rituximab Treatment for B Cell Depletion in Different Pediatric Indications
Merlin Wennmann, Simone Kathemann, Kristina Kampmann, Sinja Ohlsson, Anja Büscher, Dirk Holzinger, Adela Della Marina, Elke Lainka
Frontiers in Pediatrics.2021;[Epub] CrossRef The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center
Young Jun Ko, Young Kyu Shim, Woo Joong Kim, Soo Yeon Kim, Hunmin Kim, Hee Hwang, Jong-Hee Chae, Ji Eun Choi, Ki Joong Kim, Byung Chan Lim
Annals of Child Neurology.2020; 28(1): 30. CrossRef Rituximab Use in the Management of Childhood Nephrotic Syndrome
Mahmoud Kallash, William E. Smoyer, John D. Mahan
Frontiers in Pediatrics.2019;[Epub] CrossRef Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome
Julien Hogan, Claire Dossier, Thérésa Kwon, Marie-Alice Macher, Anne Maisin, Anne Couderc, Olivier Niel, Véronique Baudouin, Georges Deschênes
Pediatric Nephrology.2019; 34(2): 253. CrossRef Renal Tubular Complement 3 Deposition in Children with Primary Nephrotic Syndrome
Fengying Wang, Xiaozhong Li, Xueming Zhu, Qing Chen, Lu Jiang, Ziqiang Zhu
BioMed Research International.2018; 2018: 1. CrossRef
|